Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

Raid M. Aljumaily

Raid M. Aljumaily publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Lung Cancer Research Studies.

OpenAlex
World rank
#872,389
of 7,710,434 ranked researchers
Rank in United States
#288,591
of 1,627,098
Works
155
Citations
3.4k
Citations per work
21.7
h-index
24
i10-index 42Top 17% in Oncology

What does Raid M. Aljumaily research?

Raid M. Aljumaily's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (5%).

Life Sciences15%Health Sciences64%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine9963.6%
  1. Everything else3421.7%
    1. Biochemistry, Genetics and Molecular Biology159.7%
    2. Immunology and Microbiology85.0%
  1. 1Oncology42% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Molecular Biology6% of their works
  4. 4Immunology5% of their works
  5. 5Epidemiology4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Raid M. Aljumaily's research?

The keywords of their largest research topics: Immunotherapy, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Clinical Trials, Targeted Therapy, Chemotherapy and Cancer Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Immunotherapy734 topics
  2. Tumor Microenvironment702 topics
  3. Immune Checkpoint Blockade551 topic
  4. PD-1 and PD-L1551 topic
  5. Clinical Trials382 topics
  6. Targeted Therapy382 topics
  7. Chemotherapy352 topics
  8. Cancer Immunotherapy342 topics
  9. Prognostic Factors342 topics
  10. CAR T Cells241 topic
  11. Chimeric Antigen Receptor241 topic
  12. Genomic Profiles201 topic
  13. Small-Cell Lung Cancer201 topic
  14. ALK Inhibitors181 topic
  15. EGFR Mutations181 topic
  16. Pancreatic Cancer151 topic
  17. Surgical Complications151 topic
  18. Metastatic141 topic
  19. Renal Cell Carcinoma141 topic
  20. Breast Cancer111 topic
  21. CDK4/6 Inhibitors111 topic
  22. Dendritic Cells101 topic
  23. Immunity101 topic

Where does Raid M. Aljumaily work?

Raid M. Aljumaily's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Raid M. Aljumaily have?

OpenAlex counts 155 works and 3,366 citations for Raid M. Aljumaily, an h-index of 24, ranking #872,389 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Raid M. Aljumaily. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.